BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.090
-0.080 (-2.52%)
At close: May 12, 2025, 4:00 PM
3.190
+0.100 (3.24%)
After-hours: May 12, 2025, 7:45 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $11.87 million as of May 12, 2025. Its market cap has decreased by -79.42% in one year.
Market Cap
11.87M
Enterprise Value
7.26M
1-Year Change
-79.42%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $11.87M, a decrease of -64.88%. That is a compound annual growth rate of -6.41%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |